DePuy Synthes, which specializes in orthopedic and neuro products and services, has acquired 3D printing technology from Tissue Regeneration Systems (TRS). TRS is an early-stage medical device company that leverages 3D printing to develop and fabricate advanced skeletal reconstruction implants. The implants are bioresorbable, meaning that the patient's existing bone will absorb them over time with no residual foreign material left. The implants' porosity enables them to be fully integrated into the bone, and the porosity is carefully engineered to support function and bear a significant amount of load. They're created, like other 3D printed implants, from images taken from patient CT scans, making them fully customizable. Read more at